Caring for Patients with Mesothelioma: Principles and Guidelines (eBook, PDF)
Redaktion: Hesdorffer, Mary; Bates-Pappas, Gleneara E.
48,95 €
48,95 €
inkl. MwSt.
Sofort per Download lieferbar
24 °P sammeln
48,95 €
Als Download kaufen
48,95 €
inkl. MwSt.
Sofort per Download lieferbar
24 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
48,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
24 °P sammeln
Caring for Patients with Mesothelioma: Principles and Guidelines (eBook, PDF)
Redaktion: Hesdorffer, Mary; Bates-Pappas, Gleneara E.
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Offers the first focus on Long term care and survivorship regarding mesothelioma patients Highlight the development of multimodality treatment allowing for more effective and targeted treatment Encompasses all areas for mesothelioma care, treatment, and research
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Größe: 6.6MB
Andere Kunden interessierten sich auch für
Targeted Therapies in Lung Cancer: Management Strategies for Nurses and Practitioners (eBook, PDF)40,95 €
Nursing Care and ECMO (eBook, PDF)28,95 €
Dagmar RinnenburgerChronische Erkrankungen (eBook, PDF)39,99 €
The Art and Science of Personalising Care with Older People with Diabetes (eBook, PDF)36,95 €
Global Applications of Culturally Competent Health Care: Guidelines for Practice (eBook, PDF)40,95 €
Pflegewissen Pneumologie (eBook, PDF)37,99 €
Nursing Adolescents and Young Adults with Cancer (eBook, PDF)36,95 €-
-
-
Offers the first focus on Long term care and survivorship regarding mesothelioma patients
Highlight the development of multimodality treatment allowing for more effective and targeted treatment
Encompasses all areas for mesothelioma care, treatment, and research
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Springer International Publishing
- Seitenzahl: 239
- Erscheinungstermin: 22. Mai 2019
- Englisch
- ISBN-13: 9783319962443
- Artikelnr.: 56898202
- Verlag: Springer International Publishing
- Seitenzahl: 239
- Erscheinungstermin: 22. Mai 2019
- Englisch
- ISBN-13: 9783319962443
- Artikelnr.: 56898202
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Mary Hesdorffer received her undergraduate degree at the College of New Rochelle in New York and went on to receive her Masters of Science at the same institution. She is a Nurse Practitioner and spent nearly 20 years actively treating patients with mesothelioma. Ms. Hesdorffer has an expertise in the development and implementation of clinical trials. Her work has been published in peer-reviewed scientific journals and she has lectured both nationally and internationally on the topics pertaining to mesothelioma with particular emphasis on clinical trials as well as symptom and disease management. Ms. Hesdorffer has been a strong voice in urging increased transparency to the medical and legal issues surrounding mesothelioma with a strong emphasis on ethics. She is passionate in her commitment to the treatment and management of this disease and hopes to increase awareness of the need to advance the science that will lead to a cure. Mary is the Executive Director of the Mesothelioma Applied Research Foundation. Gleneara E. Bates-Pappas, LMSW, is currently a doctoral candidate at CUNY Graduate Center, an adjunct lecturer at Columbia University School of Social Work, Silberman School of Social Work at Hunter College, New York University Silver School of Social Work and a psychological counselor at CUNY School of Labor and Urban Studies. She received her bachelors degree from the University of Arizona in political science and economics minoring in Africana studies and went on to receive her master, basic science and legal training from Columbia University. Her doctoral research explores the environmental risk factors for lung cancer mortality among racially ethnic minorities living in New York. Her current research projects aim to elucidate the bio-physiological aspects of tumor resistance in response to chemotherapy and the use of telemedicine to improve quality-of-life and cognitive function in post-treatment cancer survivors. In addition to exploring ways to use virtual and augmented reality to reduce anxiety during treatment in Pediatric oncology patients. As a cancer researcher, she managed a translational research laboratory at Columbia University Medical Center where she conceptualized and conducted research on heat shock proteins and their role in tumor resistance in response to chemotherapy and the role of platinum agents in inducing checkpoint inhibitors related to tumor progression on the quality of life of patients and their primary caregivers during and post-treatment. In addition, she serves on the American Society of Clinical Oncology Cancer Survivorship Committee and The International Association for the Study of Lung Cancer Smoking Cessation Committee
Chapter 1: The history of Mesothelioma and medical research.- Part I: Mesothelioma treatment_Chapter 2: Early history of Peritoneal surgery.- Chapter 3: History of Pleural surgical treatment.- Chapter 4: History of clinical trials.- Chapter 5: Caring for patients undergoing pleural surgery.- Chapter 6: Peritoneal Treatment.- Chapter 7: Radiation Therapy.- Part II: Therapeutic treatments: chemotherapy, Biotherapy, and immunotherapy_Chapter 8: Standard Chemotherapy.- Chapter 9: Caring for patients during and after Immunotherapy treatment.- Chapter 10: Biotherapy treatment.- Part III: Supportive Health Care for treatment_Chapter 11: Pulmonary rehab.- Chapter 12: Physical therapy.- Chapter 13: Occupation therapy.- Chapter 14: Nutrition.- Chapter 15: Mental health treatment.- Chapter 16: Pain Management.- Chapter 17: Palliative Care.- Chapter 18: Long Term care and Survivorship.- Chapter 19: End- of-Life care.- Chapter 20: Patient perspective on mesothelioma treatment.- Part IV: Public health impact of asbestos world wide_Chapter 21: Public health impact of asbestos world wide: History of asbestos use.- Chapter 22: Public health impact of asbestos world wide: What is the current public health impact?.- Chapter 23: Nurse Educator Asbestos Related Diseases the Lung Foundation Australia.- Part V: The future of Mesothelioma Research_Chapter 24: Clinical Trials.- Chapter 25: Basic Science Research.- Chapter 26: Genetics and Genetic Counseling.- Part VI: Patient's perspective_Chapter 27: Patient involment in research.- Chapter 28: The development of mesothelioma foundations and patient support.- Chapter 29: The impact of social media mesothelioma.
Chapter 1: The history of Mesothelioma and medical research.- Part I: Mesothelioma treatment_Chapter 2: Early history of Peritoneal surgery.- Chapter 3: History of Pleural surgical treatment.- Chapter 4: History of clinical trials.- Chapter 5: Caring for patients undergoing pleural surgery.- Chapter 6: Peritoneal Treatment.- Chapter 7: Radiation Therapy.- Part II: Therapeutic treatments: chemotherapy, Biotherapy, and immunotherapy_Chapter 8: Standard Chemotherapy.- Chapter 9: Caring for patients during and after Immunotherapy treatment.- Chapter 10: Biotherapy treatment.- Part III: Supportive Health Care for treatment_Chapter 11: Pulmonary rehab.- Chapter 12: Physical therapy.- Chapter 13: Occupation therapy.- Chapter 14: Nutrition.- Chapter 15: Mental health treatment.- Chapter 16: Pain Management.- Chapter 17: Palliative Care.- Chapter 18: Long Term care and Survivorship.- Chapter 19: End- of-Life care.- Chapter 20: Patient perspective on mesothelioma treatment.- Part IV: Public health impact of asbestos world wide_Chapter 21: Public health impact of asbestos world wide: History of asbestos use.- Chapter 22: Public health impact of asbestos world wide: What is the current public health impact?.- Chapter 23: Nurse Educator Asbestos Related Diseases the Lung Foundation Australia.- Part V: The future of Mesothelioma Research_Chapter 24: Clinical Trials.- Chapter 25: Basic Science Research.- Chapter 26: Genetics and Genetic Counseling.- Part VI: Patient's perspective_Chapter 27: Patient involment in research.- Chapter 28: The development of mesothelioma foundations and patient support.- Chapter 29: The impact of social media mesothelioma.







